Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

  • ID: 4601547
  • Report
  • 97 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Alere Inc
  • Bio Techne Corp
  • Cepheid
  • Enzo Biochem Inc
  • MDNA Life Sciences Inc
  • Olympia Diagnostics, Inc
  • MORE
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cervical Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alere Inc
  • Bio Techne Corp
  • Cepheid
  • Enzo Biochem Inc
  • MDNA Life Sciences Inc
  • Olympia Diagnostics, Inc
  • MORE
1 Table of Contents

2 Introduction
2.1 Cervical Cancer Diagnostic Tests Overview

3 Products under Development
3.1 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials

4 Cervical Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Cervical Cancer Companies - Pipeline Products by Stage of Development
4.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development

5 Cervical Cancer Diagnostic Tests Companies and Product Overview
5.1 Alere Inc Company Overview
5.2 Augusta University Company Overview
5.3 Becton Dickinson and Co Company Overview
5.4 Bio Techne Corp Company Overview
5.5 BioAffinity Technologies, Inc. Company Overview
5.6 BioMark Diagnostics Inc. Company Overview
5.7 BioMark Technologies Inc Company Overview
5.8 Cepheid Company Overview
5.9 China Sky One Medical Inc Company Overview
5.10 Cytosystems Ltd Company Overview
5.11 Enzo Biochem Inc Company Overview
5.12 GenomicTree Inc Company Overview
5.13 GRANT Life Sciences, Inc. Company Overview
5.14 Louisville Bioscience, Inc. Company Overview
5.15 MDNA Life Sciences Inc Company Overview
5.16 MDxHealth SA Company Overview
5.17 Milagen Inc Company Overview
5.18 Olympia Diagnostics, Inc Company Overview
5.19 Oncgnostics GmbH Company Overview
5.20 ONCOVEDA Cancer Research Center Company Overview
5.21 Precision Biologics Inc Company Overview
5.22 US Biomarkers Inc Company Overview
5.23 XEPTAGEN SpA Company Overview

6 Cervical Cancer Diagnostic Tests Recent Developments
6.1 Jun 27, 2018: BD, Heart to Heart International and the NAFC Announce 2018 Grantees for a Multi-Year Point of Care Testing Initiative to Improve Patient Outcomes
6.2 Jun 12, 2018: Agilent Companion Diagnostic Gains Expanded FDA Approval in Cervical Cancer
6.3 Jun 12, 2018: Cancer Genetics Appoints Michael McCartney As Chief Commercial Officer
6.4 Jun 05, 2018: Study Finds Older Patients Who Undergo Mammography Also Are More Likely to Pursue Other Preventive Tests
6.5 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer
6.6 May 17, 2018: Quest Diagnostics adds Helen Torley to Board of Directors
6.7 May 15, 2018: Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
6.8 May 14, 2018: bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
6.9 May 07, 2018: Forbes Names Quest Diagnostics One of America's Best Large Employers
6.10 May 06, 2018: Kaskela Law: Shareholder Class Action Filed Against Cancer Genetics
6.11 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Cervical Cancer Companies - Pipeline Products by Stage of Development
Table 7: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NMP179 Test - Product Status
Table 10: NMP179 Test - Product Description
Table 11: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
Table 13: Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
Table 14: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 15: BD SurePath Plus Molecular Pap Test System - Product Status
Table 16: BD SurePath Plus Molecular Pap Test System - Product Description
Table 17: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
Table 18: Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
Table 19: Becton Dickinson and Co - Ongoing Clinical Trials Overview
Table 20: BD SurePath Plus Molecular Pap Test System - Validation of High Resolution Microendoscope in the Screening of Cervical Cancer Precursor Lesions in Brazil: UH3 - Brazil
Table 21: Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 22: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 23: RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 24: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 26: CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 27: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 29: Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 30: BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 32: Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 33: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Xpert Molecular PAP Assay - Product Status
Table 35: Xpert Molecular PAP Assay - Product Description
Table 36: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Diagnostic Kit - Carcinoma Cervix - Product Status
Table 38: Diagnostic Kit - Carcinoma Cervix - Product Description
Table 39: Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
Table 41: Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
Table 42: Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Status
Table 44: p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Description
Table 45: GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: EarlyTect Cervical Cancer Diagnostic Tests - Product Status
Table 47: EarlyTect Cervical Cancer Diagnostic Tests - Product Description
Table 48: Screening Test - Cervical Cancer Diagnostic Tests - Product Status
Table 49: Screening Test - Cervical Cancer Diagnostic Tests - Product Description
Table 50: GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Status
Table 52: Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Description
Table 53: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Cervical Cancer Remission pT Test - Product Status
Table 55: Cervical Cancer Remission pT Test - Product Description
Table 56: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Cervical Mitomic Test - Product Status
Table 58: Cervical Mitomic Test - Product Description
Table 59: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
Table 60: ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Status
Table 61: ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Description
Table 62: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Immunoassay - Cervical Cancer Diagnostic Tests - Product Status
Table 64: Immunoassay - Cervical Cancer Diagnostic Tests - Product Description
Table 65: Olympia Diagnostics, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
Table 67: Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
Table 68: Prognostic Test - Cervical Cancer Diagnostic Tests - Product Status
Table 69: Prognostic Test - Cervical Cancer Diagnostic Tests - Product Description
Table 70: Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 71: GynTect - Product Status
Table 72: GynTect - Product Description
Table 73: GynTect 2.0 - Product Status
Table 74: GynTect 2.0 - Product Description
Table 75: ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 76: HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
Table 77: HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
Table 78: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
Table 80: Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
Table 81: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Status
Table 83: Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Description
Table 84: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 85: SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Status
Table 86: SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Description
Table 87: Glossary

List of Figures
Figure 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alere Inc
  • Augusta University
  • Becton Dickinson and Co
  • Bio Techne Corp
  • BioAffinity Technologies, Inc.
  • BioMark Diagnostics Inc.
  • BioMark Technologies Inc
  • Cepheid
  • China Sky One Medical Inc
  • Cytosystems Ltd
  • Enzo Biochem Inc
  • GenomicTree Inc
  • GRANT Life Sciences, Inc.
  • Louisville Bioscience, Inc.
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Milagen Inc
  • Olympia Diagnostics, Inc
  • Oncgnostics GmbH
  • ONCOVEDA Cancer Research Center
  • Precision Biologics Inc
  • US Biomarkers Inc
  • XEPTAGEN SpA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll